NeurologyLive® Brain Games: January 8, 2023


Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is Alzheimer disease and dementia.

Welcome to NeurologyLive® Brain Games! This weekly quiz series, which goes live every Sunday morning, will feature questions on a variety of clinical and historical neurology topics, written by physicians, clinicians, and experts in the fields of neurological care and advocacy.

Test your mettle each week with 3 questions that cover a variety of aspects in the field of neurology, with a focus on dementia and Alzheimer disease, epilepsy and seizure disorders, headache and migraine, movement disorders, multiple sclerosis, neuromuscular disorders, sleep disorders, and stroke and cerebrovascular disease.

This week's questions have the theme of Alzheimer disease and dementia.

Click here to check out the prior iterations of Brain Games.

Interested in submitting quiz questions? Contact our managing editor, Matt Hoffman, via email:

Alzheimer disease is the most common form of dementia, followed by vascular dementia, Lewy body dementia, Parkinson disease dementia, frontotemporal lobar degeneration, and normal pressure hydrocephalus. Of these, which 2 are most often associated with mixed pathology, including concurrent AD?

Emil Kraepelin, a German psychiatrist who worked with Alois Alzheimer, first named "Alzheimer's Disease" in the eighth edition of his book Psychiatrie, published in what year?

Nearly a dozen types of nonvascular amyloid deposits have been described, but the types of amyloid plaques most commonly observed in AD are? (Select all that apply)

How did you do on this week's quiz? Let us know with a response to the poll below. Don't forget to share and compare your results with your friends!

How many questions did you get correct?

Related Videos
Peter J. McAllister, MD, FAAN
Video 6 - "Utilization of Neuroimaging in Alzheimer’s Disease"
Video 5 - "Contribution of Multiple Pathways to the Development of Alzheimer’s Disease"
Michael Levy, MD, PhD
Michael Levy, MD, PhD
Michael Kaplitt, MD, PhD
© 2024 MJH Life Sciences

All rights reserved.